GLPwatch
Individualised incretin-based treatment for type 2 diabetes.
Lancet · 2010
Last updated 2026-05-28| Journal | Lancet, 2010 |
|---|---|
| Citations | 11 |
| Relative citation ratio | 0.29 |
| NIH percentile | 18 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Full record and abstract on PubMed 20580425 ↗